134 related articles for article (PubMed ID: 29316711)
1. Renal Cell Carcinoma Perfusion before and after Radiofrequency Ablation Measured with Dynamic Contrast Enhanced MRI: A Pilot Study.
Wah TM; Sourbron S; Wilson DJ; Magee D; Gregory WM; Selby PJ; Buckley DL
Diagnostics (Basel); 2018 Jan; 8(1):. PubMed ID: 29316711
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer.
Ito K; Soga S; Seguchi K; Shinchi Y; Masunaga A; Tasaki S; Kuroda K; Sato A; Asakuma J; Horiguchi A; Shinmoto H; Kaji T; Asano T
Oncol Lett; 2017 Jul; 14(1):918-924. PubMed ID: 28693252
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
[TBL] [Abstract][Full Text] [Related]
4. The effects of cryoablation on renal cell carcinoma perfusion and glomerular filtration rate measured using dynamic contrast-enhanced MRI: a feasibility study.
Chapman SJ; Wah TM; Sourbron SP; Buckley DL
Clin Radiol; 2013 Sep; 68(9):887-94. PubMed ID: 23639366
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency Ablation for Renal Cancer in Von Hippel-Lindau Syndrome Patients: A Prospective Cohort Analysis.
Allasia M; Soria F; Battaglia A; Gazzera C; Calandri M; Caprino MP; Lucatello B; Velrti A; Maccario M; Pasini B; Bosio A; Gontero P; Destefanis P
Clin Genitourin Cancer; 2017 Aug; ():. PubMed ID: 28866246
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation of renal cell carcinoma.
Chiou YY; Hwang JI; Chou YH; Wang JH; Chiang JH; Chang CY
J Chin Med Assoc; 2005 May; 68(5):221-5. PubMed ID: 15909727
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
[TBL] [Abstract][Full Text] [Related]
8. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
9. Incidence of multiple sporadic renal cell carcinomas in patients referred for renal radiofrequency ablation: implications for imaging follow-up.
Beland MD; Wolf FJ; Grand DJ; Dupuy DE; Mayo-Smith WW
AJR Am J Roentgenol; 2011 Sep; 197(3):671-5. PubMed ID: 21862810
[TBL] [Abstract][Full Text] [Related]
10. Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size- and location-matched renal masses.
Sung HH; Park BK; Kim CK; Choi HY; Lee HM
Int J Hyperthermia; 2012; 28(3):227-34. PubMed ID: 22515344
[TBL] [Abstract][Full Text] [Related]
11. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
[TBL] [Abstract][Full Text] [Related]
14. Comparative Outcome of Computed Tomography-guided Percutaneous Radiofrequency Ablation, Partial Nephrectomy or Radical Nephrectomy in the Treatment of Stage T1 Renal Cell Carcinoma.
Cooper CJ; Teleb M; Dwivedi A; Rangel G; Sanchez LA; Laks S; Akle N; Nahleh Z
Rare Tumors; 2015 Feb; 7(1):5583. PubMed ID: 25918603
[TBL] [Abstract][Full Text] [Related]
15. RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome.
Park BK; Gong IH; Kang MY; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
Eur Radiol; 2018 Jul; 28(7):2979-2985. PubMed ID: 29426988
[TBL] [Abstract][Full Text] [Related]
16. Diffusion weighted MRI of osteoid osteomas: Higher ADC values after radiofrequency ablation.
Rheinheimer S; Görlach J; Figiel J; Mahnken AH
Eur J Radiol; 2016 Jul; 85(7):1284-8. PubMed ID: 27235875
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation for the treatment of renal cell carcinoma: initial experience.
Watanabe F; Kawasaki T; Hotaka Y; Ishiyama M; Fuwa S; Nagata M; Saida Y
Radiat Med; 2008 Jan; 26(1):1-5. PubMed ID: 18236127
[TBL] [Abstract][Full Text] [Related]
18. C-arm CT-guided renal arterial embolisation followed by radiofrequency ablation for treatment of patients with unresectable renal cell carcinoma.
Duan XH; Li YS; Han XW; Wang YL; Jiao DC; Li TF; Chen PF; Fang Y
Clin Radiol; 2016 Jan; 71(1):79-85. PubMed ID: 26602936
[TBL] [Abstract][Full Text] [Related]
19. Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study.
Han X; Dong J; Liu Z; Wu B; Tian Y; Tan H; Cheng W
Int J Hyperthermia; 2020; 37(1):1066-1073. PubMed ID: 32924654
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients.
Iannuccilli JD; Dupuy DE; Beland MD; Machan JT; Golijanin DJ; Mayo-Smith WW
Eur Radiol; 2016 Jun; 26(6):1656-64. PubMed ID: 26373755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
